Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Release Third Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on November 17

TEL AVIV, Israel, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
September 21, 2015 08:00 ET | Source: Alcobra Ltd.

FDA Grants Fast Track Designation to Alcobra's MDX for Fragile X Syndrome

TEL AVIV, Israel, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
August 13, 2015 07:00 ET | Source: Alcobra Ltd.

Alcobra Announces Second Quarter 2015 Financial Results and Provides Corporate Update

Conference Call & Webcast today at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
August 03, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Release Second Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on August 13

TEL AVIV, Israel, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
July 13, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Announces Election of Dr. Joao Siffert to Board of Directors

TEL AVIV, Isreal, July 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
June 24, 2015 06:00 ET | Source: Alcobra Ltd.

Alcobra Announces Results From Phase 2 Clinical Trial of MDX for Fragile X Syndrome

Study Did Not Meet Primary Endpoint of Change on the ADHD RS-IV Inattentive Subscale Statistically Significant Improvements Seen on Two Secondary Endpoints: the Vineland Adaptive Behavior Scale...
June 23, 2015 16:01 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present Results of Phase II Fragile X Trial in a Conference Call & Webcast Presentation on Wednesday, June 24

TEL AVIV, Israel, June 23, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
May 28, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at Two Conferences in June

TEL AVIV, Israel, May 28, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
May 06, 2015 07:30 ET | Source: Alcobra Ltd.

Alcobra Announces First Quarter 2015 Financial Results and Provides Corporate Update

Alcobra Provides Update on Results of FDA Meeting Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, May 6, 2015 (GLOBE NEWSWIRE) -- Alcobra...
April 27, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Participate at Two Conferences in May

TEL AVIV, Israel, April 27, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right